The Biden Administration And Biopharma: It’s Been A Tough Three Years

A round up of reform policies targeting the biopharma industry and its pricing practices that have been implemented or proposed by the Biden Administration to date.

Biden - pink perspectives
Now He Wants To Make Sure He Gets Credit For Drug Industry Reforms • Source: Shutterstock

President Biden has made drug pricing reform one of his signature initiatives and three years into his term, a number of significant programs are being implemented, mostly under the auspices of the Inflation Reduction Act of 2022. Drug pricing reform policies enacted and in the process of implementation, policies proposed and not yet implemented and industry efforts to stop one of the most impactful of the policies – Medicare price negotiation – are displayed below.

The Administration most recently advanced a policy established by the Trump Administration that would allow US importation of cheaper drugs...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Market Access

More from Pink Sheet